Latest Share Chat

Shield Thera Share News (STX)

Shield Thera Information

Buy STX Shares
Add STX to Watchlist
Add STX to Alert

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.475

Bid: 1.45

Ask: 1.50

Change: -0.075 (-4.84%)

Spread: 0.05 (3.448%)

Open: 1.55

High: 1.55

Low: 1.475

Prev. Close: 1.55

Last checked at -

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Thu, 12th Oct 2023 11:14

Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next week Friday to pursue other opportunities. The firm's company controller, Paul Spoors, will take on the CFO role on an interim basis. Shield says it has engaged an executive search firm to identify a new CFO.

Current stock price: 6.25 pence, down 6.7% on Thursday

12-month change: down 29%

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

21 Jan 2021 20:12

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

19 Jan 2021 15:04

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

15 Jan 2021 13:11

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

11 Dec 2020 16:40

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

19 Oct 2020 17:34

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

19 Oct 2020 09:12

Shield shares rise as Teva withdraws patent oppositions

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on its opposition proceedings with Teva Pharmaceutical Industries on Monday, confirming that Teva had withdrawn its appeal and opposition over two of Shield's patents.

16 Sep 2020 11:13

Latest Share Chat

Shield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

Shield shares rise as Teva withdraws patent oppositions

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

UK Shareholder Meetings Calendar - Next 7 Days

Shield Therapeutics shares rise on two recent research papers

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Latest Share Chat

Shield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Login to your account

Quickpicks are a member only feature

Login to your account